Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 283

1.

The continuous rediscovery and the benefit-risk ratio of thioguanine, a comprehensive review.

Bayoumy AB, Simsek M, Seinen ML, Mulder CJJ, Ansari A, Peters GJ, De Boer NK.

Expert Opin Drug Metab Toxicol. 2020 Feb 24:1-13. doi: 10.1080/17425255.2020.1719996. [Epub ahead of print]

PMID:
32090622
2.

Human transmission of Blastocystis by Fecal Microbiota Transplantation without development of gastrointestinal symptoms in recipients.

Terveer EM, van Gool T, Ooijevaar RE, Sanders IMJG, Boeije-Koppenol E, Keller JJ, Bart A, Kuijper EJ, Terveer EM, Vendrik K, Ooijevaar R, van Lingen E, Boeije-Koppenol E, van Beurden Y, Bauer MP, van Nood E, Goorhuis A, Seegers JFML, Dijkgraaf MGW, Mulder CJJ, Vandenbroucke-Grauls CMJE, Verspaget HW, Kuijper EJ, Keller JJ.

Clin Infect Dis. 2019 Nov 15. pii: ciz1122. doi: 10.1093/cid/ciz1122. [Epub ahead of print]

PMID:
31728525
3.

Cladribine repurposed in multiple sclerosis: making a fortune out of a generic drug.

Buiter HJC, Derijks L, Mulder CJJ.

Eur J Hosp Pharm. 2019 Sep;26(5):246-247. doi: 10.1136/ejhpharm-2019-002026. Epub 2019 Aug 30. No abstract available.

4.

Celiac Disease: Against the Grain in Gastroenterology.

Zhu J, Mulder CJJ, Dieleman LA.

J Can Assoc Gastroenterol. 2019 Dec;2(4):161-169. doi: 10.1093/jcag/gwy042. Epub 2018 Jul 18.

5.

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators.

Lancet Gastroenterol Hepatol. 2019 Dec;4(12):960-970. doi: 10.1016/S2468-1253(19)30265-1. Epub 2019 Sep 4.

PMID:
31494097
6.

Celiac disease in the East and the West: Bridging the gaps between the guidelines and their implementation in daily practice is mandatory.

Dhawan A, Agarwal A, Mulder CJ, Makharia GK.

Indian J Gastroenterol. 2019 Jun;38(3):185-189. doi: 10.1007/s12664-019-00970-7. Review. No abstract available.

PMID:
31313236
7.

European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.

Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, Mulder CJ, Lundin KEA.

United European Gastroenterol J. 2019 Jun;7(5):583-613. doi: 10.1177/2050640619844125. Epub 2019 Apr 13. Review.

8.

Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients.

van Asseldonk DP, Simsek M, de Boer NKH, Jharap B, Bloemena E, den Hartog G, Westerveld DB, Becx MC, Russel MG, Lissenberg-Witte BI, van Nieuwkerk CM, Mulder CJJ, Verheij J, van Bodegraven AA.

Scand J Gastroenterol. 2019 Jun;54(6):753-760. doi: 10.1080/00365521.2019.1629006. Epub 2019 Jun 16.

PMID:
31203688
9.

Faecal Scent as a Novel Non-Invasive Biomarker to Discriminate between Coeliac Disease and Refractory Coeliac Disease: A Proof of Principle Study.

Rouvroye MD, Wicaksono A, Bosch S, Savelkoul E, Covington JA, Beaumont H, Mulder CJ, Bouma G, de Meij TGJ, de Boer NKH.

Biosensors (Basel). 2019 May 27;9(2). pii: E69. doi: 10.3390/bios9020069.

10.

Sustained effectiveness, safety and therapeutic drug monitoring of tioguanine in a cohort of 274 IBD patients intolerant for conventional therapies.

Simsek M, Deben DS, Horjus CS, BĂ©nard MV, Lissenberg-Witte BI, Buiter HJC, van Luin M, Seinen ML, Mulder CJJ, Wong DR, de Boer NKH, van Bodegraven AA.

Aliment Pharmacol Ther. 2019 Jul;50(1):54-65. doi: 10.1111/apt.15280. Epub 2019 May 16.

11.

Accommodations and Adaptations to Overcome Workplace Disability in Inflammatory Bowel Disease Patients: A Systematic Review.

Paulides E, Gearry RB, de Boer NKH, Mulder CJJ, Bernstein CN, McCombie AM.

Inflamm Intest Dis. 2019 Feb;3(3):138-144. doi: 10.1159/000495293. Epub 2019 Jan 3.

12.

Low-FODMAP Diet Is Associated With Improved Quality of Life in IBS Patients-A Prospective Observational Study.

Kortlever TL, Ten Bokkel Huinink S, Offereins M, Hebblethwaite C, O'Brien L, Leeper J, Mulder CJJ, Barrett JS, Gearry RB.

Nutr Clin Pract. 2019 Aug;34(4):623-630. doi: 10.1002/ncp.10233. Epub 2019 Jan 15.

PMID:
30644587
13.

Patient-Reported Experiences with a Relicensed Generic: Thioguanine for the Treatment of Inflammatory Bowel Diseases.

Simsek M, Markus-de Kwaadsteniet TML, van der Horst D, Mulder CJJ, de Boer NKH.

J Gastrointestin Liver Dis. 2018 Dec;27(4):385-389. doi: 10.15403/jgld.2014.1121.274.tor.

14.

Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones.

de Boer NKH; Thiopurine Working Group.

Gastroenterology. 2019 Jan;156(1):11-14. doi: 10.1053/j.gastro.2018.11.039. Epub 2018 Nov 22. No abstract available.

PMID:
30472233
15.

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

van den Brand FF, van der Veen KS, de Boer YS, van Gerven NM, Lissenberg-Witte BI, Beuers U, van Erpecum KJ, van Buuren HR, den Ouden JW, Brouwer JT, Vrolijk JM, Verdonk RC, van Hoek B, Koek GH, Drenth JPH, Guichelaar MMJ, Mulder CJJ, Bloemena E, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study Group.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):940-947.e2. doi: 10.1016/j.cgh.2018.09.046. Epub 2018 Oct 3.

PMID:
30291909
16.

The daily practice of (suspected) coeliac disease management by general practitioners: A qualitative approach.

van Gils T, Senler TG, van der Horst HE, Mulder CJJ, Bouma G, de Vries H.

Eur J Gen Pract. 2018 Dec;24(1):236-242. doi: 10.1080/13814788.2018.1516203.

17.

Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version.

Paulides E, Kim C, Frampton C, Gearry RB, Eglinton T, Leong RW, de Boer NKH, Mulder CJJ, McCombie AM.

J Gastroenterol Hepatol. 2019 Jan;34(1):92-102. doi: 10.1111/jgh.14496. Epub 2018 Oct 25.

PMID:
30276858
18.

Elongated Styloid Processes of the Temporal Bone as a Cause of Dysphagia.

Ishaq S, Jama GM, Danino J, Hall A, Mulder CJJ, Molony N.

ACG Case Rep J. 2018 Sep 12;5:e63. doi: 10.14309/crj.2018.63. eCollection 2018. No abstract available.

19.

The teratogenicity of allopurinol: A comprehensive review of animal and human studies.

Simsek M, Opperman RCM, Mulder CJJ, Lambalk CB, de Boer NKH.

Reprod Toxicol. 2018 Oct;81:180-187. doi: 10.1016/j.reprotox.2018.08.012. Epub 2018 Aug 17. Review.

20.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, de Boer YS, de Boer NKH, Mulder CJJ, Bloemena E, Bakker CM, Vrolijk JM, Drenth JPH, Tan ACITL, Ter Borg F, Ter Borg MJ, van den Hazel SJ, Inderson A, Tushuizen ME, Bouma G.

Aliment Pharmacol Ther. 2018 Oct;48(7):761-767. doi: 10.1111/apt.14939. Epub 2018 Aug 15.

Supplemental Content

Loading ...
Support Center